Pure Biologics establishes Doto Medical special purpose vehicle

Pure Biologics establishes the Doto Medical special purpose vehicle and signs an agreement with the renowned international business advisor Clairfield Partners to accelerate the commercialization of the PB103 aptamer project.

News

Inquiries

Pure Biologics’ publication in the Journal of Biomedical Science

28 January

2021

Pure Biologics’ publication in the Journal of Biomedical Science

Klaus, T., Deshmukh, S. pH-responsive antibodies for therapeutic applications. J Biomed Sci 28, 11 (2021)

PB012 PureApta on the NCBR beneficiaries’ list of successes

12 January

2021

PB012 PureApta on the NCBR beneficiaries’ list of successes

The National Center for Research and Development placed the project on the list of beneficiaries' successes.

PB001 project – the first pre-clinical panel is underway

8 January

2021

PB001 project – the first pre-clinical panel is underway

The research is carried out by Timeline Bioresearch, experienced in immuno-oncology and intestinal cancer models.

Pure Biologics debut on the WSE Main Market – news

16 December

2020

Pure Biologics debut on the WSE Main Market – news

News on the debut of Pure Biologics on the WSE Main Market in key business and industry media.

Debut on the WSE Main Market, 14.12.2020 (on-line)

11 December

2020

Debut on the WSE Main Market, 14.12.2020 (on-line)

Pure Biologics debut on the Regulated Market of the Warsaw Stock Exchange.

9 October

2020

Pure Biologics establishes Doto Medical special purpose vehicle

Pure Biologics’ publication in the Journal of Biomedical Science

PB012 PureApta on the NCBR beneficiaries’ list of successes

PB001 project – the first pre-clinical panel is underway

Pure Biologics debut on the WSE Main Market – news

Debut on the WSE Main Market, 14.12.2020 (on-line)

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/2/20 25.01.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/1/20 21.01.2020